Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe.
Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe.
复制标题
DOI:
10.1038/cddis.2014.412
复制
发表时间:
2014-10-02
影响因子:
9
通讯作者:
中科院分区:
文献类型:
--
作者:
Glioblastoma multiforme is resistant to conventional anti-tumoral treatments due to its infiltrative nature and capability of relapse; therefore, research efforts focus on characterizing gliomagenesis and identifying molecular targets useful on therapy. New therapeutic strategies are being tested in patients, such as Histone deacetylase inhibitors (HDACi) either alone or in combination with other therapies. Here two HDACi included in clinical trials have been tested, suberanilohydroxamic acid (SAHA) and valproic acid (VPA), to characterize their effects on glioma cell growth in vitro and to determine the molecular changes that promote cancer cell death. We found that both HDACi reduce glioma cell viability, proliferation and clonogenicity. They have multiple effects, such as inducing the production of reactive oxygen species (ROS) and activating the mitochondrial apoptotic pathway, nevertheless cell death is not prevented by the pan-caspase inhibitor Q-VD-OPh. Importantly, we found that HDACi alter cell cycle progression by decreasing the expression of G2 checkpoint kinases Wee1 and checkpoint kinase 1 (Chk1). In addition, HDACi reduce the expression of proteins involved in DNA repair (Rad51), mitotic spindle formation (TPX2) and chromosome segregation (Survivin) in glioma cells and in human glioblastoma multiforme primary cultures. Therefore, HDACi treatment causes glioma cell entry into mitosis before DNA damage could be repaired and to the formation of an aberrant mitotic spindle that results in glioma cell death through mitotic catastrophe-induced apoptosis.
登录
查看更多内容
影响因子:
3.8
作者:
Lucio-Eterovic AK;Cortez MA;Valera ET;Motta FJ;Queiroz RG;Machado HR;Carlotti CG Jr;Neder L;Scrideli CA;Tone LG
通讯作者:
Tone LG
DOI:
10.1073/pnas.0409130102
发表时间:
2005-01-25
影响因子:
11.1
作者:
Huang, XX;Tran, T;Zhang, PM
通讯作者:
Zhang, PM
DOI:
10.1158/1078-0432.ccr-12-0647
发表时间:
2013-02-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Guvenc H;Pavlyukov MS;Joshi K;Kurt H;Banasavadi-Siddegowda YK;Mao P;Hong C;Yamada R;Kwon CH;Bhasin D;Chettiar S;Kitange G;Park IH;Sarkaria JN;Li C;Shakhparonov MI;Nakano I
通讯作者:
Nakano I
影响因子:
7.5
作者:
Lens, Susanne M. A.;Vader, Gerben;Medema, Rene H.
通讯作者:
Medema, Rene H.
影响因子:
8
作者:
Castedo, M;Perfettini, JL;Kroemer, G
通讯作者:
Kroemer, G